Bionano Genomics (BNGO) Operating Income (2017 - 2025)
Historic Operating Income for Bionano Genomics (BNGO) over the last 9 years, with Q3 2025 value amounting to -$8.5 million.
- Bionano Genomics' Operating Income rose 8055.17% to -$8.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$36.7 million, marking a year-over-year increase of 6859.35%. This contributed to the annual value of -$104.0 million for FY2024, which is 5169.09% up from last year.
- According to the latest figures from Q3 2025, Bionano Genomics' Operating Income is -$8.5 million, which was up 8055.17% from -$7.8 million recorded in Q2 2025.
- Bionano Genomics' Operating Income's 5-year high stood at -$7.8 million during Q2 2025, with a 5-year trough of -$113.2 million in Q3 2023.
- Its 5-year average for Operating Income is -$29.1 million, with a median of -$28.8 million in 2021.
- In the last 5 years, Bionano Genomics' Operating Income tumbled by 25214.78% in 2023 and then soared by 8055.17% in 2025.
- Over the past 5 years, Bionano Genomics' Operating Income (Quarter) stood at -$28.8 million in 2021, then plummeted by 30.38% to -$37.5 million in 2022, then soared by 33.51% to -$25.0 million in 2023, then skyrocketed by 52.15% to -$11.9 million in 2024, then increased by 28.5% to -$8.5 million in 2025.
- Its Operating Income stands at -$8.5 million for Q3 2025, versus -$7.8 million for Q2 2025 and -$8.5 million for Q1 2025.